Share
Title
Code
Session Type
Track
Channel
Date Time
Local Date Time
Moderator:

HIV prevention methods are evolving rapidly, particularly for women at increased vulnerability to HIV acquisition. This session will explore the options for intravaginal ring products, the relevant regulatory approvals that exist for them, and what the next generation of intravaginal products will offer.

2 min
Introduction
Nyaradzo Mavis MGODI, University of Zimbabwe, Zimbabwe
10 min
MPT issue: Overcoming challenges of contraceptive efficacy and safety and acceptability of IVR; and current evidence on anti-HSV-2 and anti-HIV IVR activity
Andrea THURMAN, CONRAD, Vanuatu
PDF
10 min
WHO, EMA and other regulatory approvals (where we are)
Meg DOHERTY, World Health Organization, Switzerland
PDF

10 min
What is next in the pipeline for IVR products?
Sharon HILLIER, Magee-Womens Research Institute, United States
18 min
Live Q&A
Andrea THURMAN, CONRAD, Vanuatu
Meg DOHERTY, World Health Organization, Switzerland
Sharon HILLIER, Magee-Womens Research Institute, United States
Nyaradzo Mavis MGODI, University of Zimbabwe, Zimbabwe
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT